Active Infection & Immunity Lungs & Breathing

Neutrophils re-entering the circulation from a primary site of inflammation: Physiological or pathological?

In plain English

AI plain-English summary

Neutrophils—the immune system’s first responders—sometimes crawl out of a blood vessel toward an infection, then turn around and re-enter the bloodstream. This project investigates why they do that, and whether the reversal helps or harms the body. Most research assumes neutrophils exit a blood vessel and stay put. But the applicant has shown that some neutrophils perform reverse transendothelial migration (rTEM), and that these cells carry an activated, pro-inflammatory state linked to damage in distant organs like the lungs or kidneys. What remains unknown is how common rTEM neutrophils are, what molecular markers define them, and whether they play a role in ageing. The project will also test a new idea: that rTEM neutrophils might sometimes protect the host against pathogens, rather than just causing collateral harm. This is fundamental science. It does not promise a new drug or diagnostic tomorrow. But understanding why a subset of neutrophils re-enters circulation—and whether that behaviour is physiological or pathological—could reshape how researchers think about immune-driven tissue damage in sepsis, chronic inflammation, and age-related disease. Similar discoveries about immune cell behaviour have, in the past, opened entirely new avenues for therapy.

View original technical description
Neutrophils contribute to the killing and clearance of pathogens as well as initiate inflammation resolution and tissue repair processes. Furthermore, the established phenotypic and functional diversity of neutrophils have markedly extended the physiological and pathological roles of these myeloid cells. Building on the developing concept of neutrophil heterogeneity in disease settings, and significant mechanistic and pathophysiological data from the applicant, the present project aims to acquire an in-depth understanding of one population of disease-inducing neutrophils, namely neutrophils that have exhibited reverse transendothelial cells migration (rTEM). This phenomenon describes cells that initiate diapedesis, engage with endothelial cell (EC) junctions but then exhibit retrograde motility and re-enter the vascular lumen. Crucially, we have ample evidence that rTEM bestows an activation state on neutrophils in vivo, and that rTEM neutrophils are aligned with remote organ damage. Thus, exploiting recent technological advancements and capabilities, the current proposal aims to gain an in-depth understanding of the prevalence, molecular signature and pathogenic role of this “subset” of neutrophils, most notably in ageing. Furthermore, hypothesizing that the activation state of rTEM neutrophils maybe beneficial for the host, the project will for the first time explore the potential protective, and thus physiological, role of rTEM neutrophils against pathogens.

View the original record at the funder ↗

Researchers

Sussan Nourshargh (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Mode and dynamics of neutrophil transmigration in vivo: Mechanisms and implications to pathological inflammation .
Investigation of the extent and outcome of neutrophil 'retro-transmigration' to draining lymph nodes
Characterising neutrophil reverse migration using wet and dry experimentation
The uncharted journeys of inflammatory cells and their functional implications
Impact of a neutrophil subpopulation infiltrating the lymph nodes on T-cell effector functions during ischemia-reperfusion injury: A new cellular target for immunotherapy?

Original classification

Investigator Award in Science

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.